Lactulose / therapeutic use
Showing 1 - 25 of >10,000
Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)
Not yet recruiting
- Non-muscular Invasive Bladder Cancer
- BCG for therapeutic use
-
Changsha, ChinaHunan Cancer Hospital
Oct 20, 2023
Head Neck Cancer Trial (PET-MRI)
Not yet recruiting
- Head and Neck Cancer
- PET-MRI
- (no location specified)
Sep 4, 2023
Severe Acute Malnutrition, Cognitive Impairment, Wasting Trial (C-RUTF (Ready-to-Use Therapeutic Food with added choline),
Not yet recruiting
- Severe Acute Malnutrition
- +3 more
- C-RUTF (Ready-to-Use Therapeutic Food with added choline)
- +2 more
- (no location specified)
Nov 28, 2023
Severe Acute Malnutrition Trial in Jakarta (Ready-to-use therapeutic food with heat stabilized rice bran, Ready-to-use
Recruiting
- Severe Acute Malnutrition
- Ready-to-use therapeutic food with heat stabilized rice bran
- Ready-to-use therapeutic food (no rice bran)
-
Jember, East Java, IndonesiaSavica
Dec 14, 2022
Alcohol Use Disorder (AUD), Alcohol-Related Disorders, Alcohol Use Trial in New Haven (0.3mg/kg/min Dimethyltryptamine + Normal
Not yet recruiting
- Alcohol Use Disorder (AUD)
- +2 more
- 0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion
- +2 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Oct 1, 2023
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li，MD
Apr 18, 2023
Substance Use Disorders Trial in Baltimore (IPS Plus Abstinence-Contingent Wage Supplement)
Recruiting
- Substance Use Disorders
- IPS Plus Abstinence-Contingent Wage Supplement
-
Baltimore, MarylandCenter for Learning and Health
Dec 21, 2022
Substance Use Disorders, Substance-Related Disorders Trial in Manchester (Laddr® plus Behavioral- Group and individual
Recruiting
- Substance Use Disorders
- Substance-Related Disorders
- Laddr® plus Behavioral- Group and individual counseling
- Behavioral- Group and individual counseling
-
Manchester, New HampshireFarnum Center
Dec 15, 2022
Stress Disorders, Post-Traumatic, Alcohol Use Disorder Trial (Propranolol, Placebo)
Not yet recruiting
- Stress Disorders, Post-Traumatic
- Alcohol Use Disorder
- Propranolol
- Placebo
- (no location specified)
Jan 20, 2023
Substance Related Disorder, Personality Disorders Trial in Toulouse (The MAURISSE application use, Usual care)
Not yet recruiting
- Substance Related Disorder
- Personality Disorders
- The MAURISSE application use
- Usual care
-
Toulouse, FranceUniversity Hospital of Toulouse
Jul 18, 2023
Cigarette Smoking-Related Carcinoma Trial in Seattle (Online Smoking Cessation Intervention, Questionnaire Administration,
Not yet recruiting
- Cigarette Smoking-Related Carcinoma
- Online Smoking Cessation Intervention
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Apr 27, 2023
Autism Spectrum Disorder, ADHD, Neurodevelopmental Disorders Trial in Foggia (repetitive Transcranial Magnetic Stimulation)
Recruiting
- Autism Spectrum Disorder
- +2 more
- repetitive Transcranial Magnetic Stimulation
-
Foggia, ItalyNeuropsychiatric Unit for Child and Adolescent, at General Hospi
Sep 29, 2023
Hepatic Encephalopathy Stage 2, Hepatic Encephalopathy Stage 3, Hepatic Encephalopathy Stage 4 Trial in Pakistan (Polyethylene
Not yet recruiting
- Hepatic Encephalopathy Stage 2
- +2 more
- Polyethylene Glycols
- +2 more
-
Quetta, Balochistan, Pakistan
- +5 more
Jun 16, 2023
Study to Evaluate Effects of Concurrent Therapy of Sarpogrelate
Completed
- Arteriosclerosis Obliterans
-
Busan, Korea, Republic ofBuKyung Kim
Nov 14, 2022
Severe Acute Malnutrition Trial in Jakarta (Ready to use therapeutic foods)
Completed
- Severe Acute Malnutrition
- Ready to use therapeutic foods
-
Jakarta, IndonesiaSavica
Nov 7, 2022
Moderate Acute Malnutrition Trial (ready-to-use supplementary food (RUSF), ready-to-use therapeutic food (RUTF), Amoxicillin)
Not yet recruiting
- Moderate Acute Malnutrition
- ready-to-use supplementary food (RUSF)
- +2 more
- (no location specified)
Sep 20, 2023
Tobacco Use Disorder, Alcohol Use Disorder, Smoking Cessation Trial (Cytisine, Placebo)
Not yet recruiting
- Tobacco Use Disorder
- +2 more
- Cytisine
- Placebo
- (no location specified)
Feb 6, 2023
Opioid-use Disorder Trial in New York, Gig Harbor (reSET-O, PEAR-008)
Completed
- Opioid-use Disorder
- reSET-O
- PEAR-008
-
New York, New York
- +1 more
Dec 13, 2022
Healthy Trial in Merksem (Indomethacin, Lactulose-mannitol)
Completed
- Healthy
- Indomethacin
- Lactulose-mannitol
-
Merksem, BelgiumClinical Pharmacology Unit
Jun 22, 2021
Severe Acute Malnutrition Trial (ready-to-use therapeutic food (RUTF), Amoxicillin)
Not yet recruiting
- Severe Acute Malnutrition
- ready-to-use therapeutic food (RUTF)
- Amoxicillin
- (no location specified)
Sep 24, 2023
E-health Therapeutic Education Application for Osteoarthritis
Completed
- Osteo Arthritis Knee
- Application ARTHe
-
Clermont-Ferrand, Aura, FranceClermont-Ferrand University Hospital
Jul 8, 2022
Adverse Effects in the Therapeutic Use of Analgesic, Antipyretic and Anti-Inflammatory Drug, Unspecified Trial (Cocktail
Not yet recruiting
- Adverse Effects in the Therapeutic Use of Analgesic, Antipyretic and Anti-Inflammatory Drug, Unspecified
- Cocktail injection
- (no location specified)
Nov 5, 2023
Opioid Use Disorder Trial in Salt Lake City (MORE-VR, Treatment as Usual)
Not yet recruiting
- Opioid Use Disorder
- MORE-VR
- Treatment as Usual
-
Salt Lake City, UtahUniversity of Utah
Sep 3, 2023
About Psychedelics Using in Psychiatric Disorders
Not yet recruiting
- Psychiatric Disorder
- Interview
- (no location specified)
Aug 22, 2023
Opioid Use Disorder Trial in Washington (PEAR-002B, reSET-O)
Completed
- Opioid Use Disorder
- PEAR-002B
- reSET-O
-
Berlin, New JerseyHassman Research Institute, LLC
Jan 5, 2023